Technical Analysis for INDV - Indivior Plc

Grade Last Price % Change Price Change
F 1520.00 0.93% 14.00
INDV closed up 0.93 percent on Tuesday, April 23, 2024, on 70 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Apr 25
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish 0.93%
Lower Bollinger Band Walk Weakness 0.93%
Outside Day Range Expansion 0.93%
Down 3 Days in a Row Weakness 0.93%
Gapped Down Weakness 0.93%
Lower Bollinger Band Touch Weakness 0.93%

   Recent Intraday Alerts

Alert Time
1.5x Volume Pace about 14 hours ago
Down 1% about 19 hours ago
Lower Bollinger Band Support about 19 hours ago
Lower Bollinger Band Support 1 day ago
Fell Below Previous Day's Low 1 day ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Indivior Plc Description

Indivior PLC (Indivior) is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and sale of prescription drugs that are based on buprenorphine for treatment of opioid dependence segment. The Company's treatment and pipeline focuses on opioid use disorder, alcohol use disorder, overdose rescue and co-morbidities of addiction/schizophrenia. Indivior's products, which are sold in over 40 countries, consist of Suboxone film (buprenorphine and naloxone), Suboxone tablet (buprenorphine and naloxone) and Subutex tablet (buprenorphine sublingual tablet), all of which are used to treat opioid dependence. Its Buprenorphine lifecycle includes Suboxone Tablet, Suboxone Film, Buprenorphine Monthly Depot and Oral Swallowable Capsule. Its overdose rescue product category includes Cocaine Esterase. Its alcohol use disorders product category includes Arbaclofen Placarbil. Its adjacency-schizophrenia product category includes Risperidone Monthly Depot.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Pipe Drugs Disorders Rescue D Pipeline Erase Alcohols Opioids

Is INDV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1927.0
52 Week Low 1127.0
Average Volume 292,283
200-Day Moving Average 1555.52
50-Day Moving Average 1606.38
20-Day Moving Average 1617.70
10-Day Moving Average 1554.60
Average True Range 53.71
RSI (14) 37.89
ADX 25.77
+DI 10.27
-DI 24.87
Chandelier Exit (Long, 3 ATRs) 1589.86
Chandelier Exit (Short, 3 ATRs) 1639.14
Upper Bollinger Bands 1763.10
Lower Bollinger Band 1472.30
Percent B (%b) 0.16
BandWidth 17.98
MACD Line -28.87
MACD Signal Line -10.63
MACD Histogram -18.2403
Fundamentals Value
Market Cap 2.06 Billion
Num Shares 136 Million
EPS -1.34
Price-to-Earnings (P/E) Ratio -1134.33
Price-to-Sales 1.81
Price-to-Book 48.69
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1580.00
Resistance 3 (R3) 1573.33 1546.67 1570.00
Resistance 2 (R2) 1546.67 1531.39 1550.00 1566.66
Resistance 1 (R1) 1533.33 1521.95 1540.00 1540.00 1563.33
Pivot Point 1506.67 1506.67 1510.00 1510.00 1506.67
Support 1 (S1) 1493.33 1491.39 1500.00 1500.00 1476.67
Support 2 (S2) 1466.67 1481.95 1470.00 1473.34
Support 3 (S3) 1453.33 1466.67 1470.00
Support 4 (S4) 1460.00